Trademark Overview
On Friday, March 22, 2024, a trademark application was filed for TRAVAGUS with the United States Patent and Trademark Office. The USPTO has given the TRAVAGUS trademark a serial number of 98462792. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, December 10, 2024. This trademark is owned by taVNS AB. The TRAVAGUS trademark is filed in the Advertising, Business and Retail Services, Computer & Software Products & Electrical & Scientific Products, Medical Instrument Products, and Medical & Beauty Services & Agricultural Services categories with the following description:
Data processing apparatus; Headsets; Data collection apparatus, namely for saving physiological user data to facilitate tuning of optimal settings for future therapeutic sessions; Electronic devices for electrical impulses to nerves and tissue for non-medical purposes
Apparatus and instruments for medical use, namely for physiological user data, nerve stimulation data and for stimulation pulses; Medical apparatus and instruments for electrical stimulation for transcutaneous auricular vagus nerve stimulation (taVNS); apparatus and instruments, namely medical devices for use to alleviate chronic inflammatory and chronic neuropathic pain. The medical devices shall also correct chronic as well as acute dysregulated inflammation. All chronic inflammatory diseases and exaggerated acute inflammatory conditions are caused by dysregulated inflammation
Providing medical treatment of epilepsy, depression, anxiety disorders, obesity, migraine, cluster headaches, insomnia, neuropathic pain, inflammatory pain, back pain, chronic pain, cognitive decline, inflammatory diseases, such as rheumatoid arthritis, osteoarthritis, psoriasis, diabetes mellitus type 1 and type 2, Crohn's disease, ulcerative colitis, systemic lupus erythematosus (SLE), asthma, chronic obstructive pulmonary diseases, multiple sclerosis and Alzheimer's disease, atherosclerosis, metabolic syndrome, obesitas
Apparatus and instruments for medical use, namely for physiological user data, nerve stimulation data and for stimulation pulses; Medical apparatus and instruments for electrical stimulation for transcutaneous auricular vagus nerve stimulation (taVNS); apparatus and instruments, namely medical devices for use to alleviate chronic inflammatory and chronic neuropathic pain. The medical devices shall also correct chronic as well as acute dysregulated inflammation. All chronic inflammatory diseases and exaggerated acute inflammatory conditions are caused by dysregulated inflammation